Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Net Income (2016 - 2025)

Historic Net Income for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$13.1 million.

  • InspireMD's Net Income fell 5423.07% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.9 million, marking a year-over-year decrease of 5661.57%. This contributed to the annual value of -$32.0 million for FY2024, which is 6069.99% down from last year.
  • InspireMD's Net Income amounted to -$13.1 million in Q3 2025, which was down 5423.07% from -$13.0 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Net Income registered a high of -$3.2 million during Q1 2021, and its lowest value of -$13.1 million during Q3 2025.
  • Moreover, its 5-year median value for Net Income was -$5.3 million (2023), whereas its average is -$6.6 million.
  • In the last 5 years, InspireMD's Net Income plummeted by 8546.7% in 2021 and then soared by 223.16% in 2023.
  • Quarter analysis of 5 years shows InspireMD's Net Income stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then decreased by 20.57% to -$5.8 million in 2023, then plummeted by 61.28% to -$9.4 million in 2024, then tumbled by 39.33% to -$13.1 million in 2025.
  • Its Net Income stands at -$13.1 million for Q3 2025, versus -$13.0 million for Q2 2025 and -$11.5 million for Q1 2025.